Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 541 AL 555

[The role of astrocytes, circadian rhythms and light pollution in the pathogenesis of Alzheimer's disease]

Gorbachevskii AV, Kicherova OA, Reikhert LI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(6):20-25. doi: 10.17116/jnevro202412406120.

Emerging role of Metformin in Alzheimer's disease: A translational view

Ríos JA, Bórquez JC, Godoy JA, Zolezzi JM, Furrianca MC, Inestrosa NC.

Ageing Res Rev. 2024 Sep;100:102439. doi: 10.1016/j.arr.2024.102439. Epub 2024 Jul 27.

Treating Alzheimer's disease with brain stimulation: From preclinical models to non-invasive stimulation in humans

Lanni I, Chiacchierini G, Papagno C, Santangelo V, Campolongo P.

Neurosci Biobehav Rev. 2024 Oct;165:105831. doi: 10.1016/j.neubiorev.2024.105831. Epub 2024 Jul 27.

How to address the complexity of multi-targeted drug discovery for Alzheimer's disease?

González JF, Sánchez-Montero JM.

Expert Opin Drug Discov. 2024 Oct;19(10):1149-1152. doi: 10.1080/17460441.2024.2385576. Epub 2024 Jul 29.

Aducanumab: A look two years after its approval

Torres A, Camargo L, López N.

Biomedica. 2024 May 31;44(Sp. 1):42-46. doi: 10.7705/biomedica.6967.

Linking APOE4/4 genotype to microglial lipid droplets and neurotoxicity in Alzheimer's disease

Huang H, Xiang R, Yan R.

Transl Neurodegener. 2024 Jul 30;13(1):38. doi: 10.1186/s40035-024-00433-w.

Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease

Kamath AP, Nayak PG, John J, Mutalik S, Balaraman AK, Krishnadas N.

Neuropharmacology. 2024 Nov 15;259:110096. doi: 10.1016/j.neuropharm.2024.110096. Epub 2024 Jul 29.

The potential role of gut microbiota-derived metabolites as regulators of metabolic syndrome-associated mitochondrial and endolysosomal dysfunction in Alzheimer's disease

Jung YH, Chae CW, Han HJ.

Exp Mol Med. 2024 Aug;56(8):1691-1702. doi: 10.1038/s12276-024-01282-3. Epub 2024 Aug 1.

Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease

Abdulhameed N, Babin A, Hansen K, Weaver R, Banks WA, Talbot K, Rhea EM.

Alzheimers Res Ther. 2024 Aug 1;16(1):173. doi: 10.1186/s13195-024-01537-1.

Molecular mechanism and therapeutic strategy of bile acids in Alzheimer's disease from the emerging perspective of the microbiota-gut-brain axis

Wu M, Cheng Y, Zhang R, Han W, Jiang H, Bi C, Zhang Z, Ye M, Lin X, Liu Z.

Biomed Pharmacother. 2024 Sep;178:117228. doi: 10.1016/j.biopha.2024.117228. Epub 2024 Jul 31.

Chromenone: An emerging scaffold in anti-Alzheimer drug discovery

Agarwal U, Verma S, Tonk RK.

Bioorg Med Chem Lett. 2024 Oct 1;111:129912. doi: 10.1016/j.bmcl.2024.129912. Epub 2024 Jul 30.

Pros and Cons of APOE4 Homozygosity and Effects on Neuroplasticity, Malnutrition, and Infections in Early Life Adversity, Alzheimer's Disease, and Alzheimer's Prevention

Oriá RB, Smith CJ, Ashford JW, Vitek MP, Guerrant RL.

J Alzheimers Dis. 2024;100(s1):S179-S185. doi: 10.3233/JAD-240888.

Therapeutic potential of plant-derived natural compounds in Alzheimer's disease: Targeting microglia-mediated neuroinflammation

Shen Y, Liu F, Zhang M.

Biomed Pharmacother. 2024 Sep;178:117235. doi: 10.1016/j.biopha.2024.117235. Epub 2024 Aug 1.

REELIN ameliorates Alzheimer's disease, but how?

Katsuyama Y, Hattori M.

Neurosci Res. 2024 Nov;208:8-14. doi: 10.1016/j.neures.2024.07.004. Epub 2024 Jul 31.

Comparison of AI with and without hand-crafted features to classify Alzheimer's disease in different languages

Kim TM, Son J, Chun JW, Lee Y, Kim DJ, Choi IY, Ko T, Choi S.

Comput Biol Med. 2024 Sep;180:108950. doi: 10.1016/j.compbiomed.2024.108950. Epub 2024 Aug 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias